News

Gladstone in the News November 3, 2022

Medical Milestones Are Underway at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.

Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs

Article September 9, 2022

New Antiviral Therapy May Block COVID-19 Transmission

The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus

News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab Chaturvedi

Article May 12, 2022

Throwing Drug Resistance for a Loop

New class of resistance-proof drugs could one day transform treatments for viral diseases

News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab Chaturvedi

Gladstone in the News March 9, 2022

Three Ways to Strengthen a Collaborative Culture

The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab

Article March 1, 2022

Gladstone Science Has Three Chances to Win STAT Madness

Gladstone discoveries compete head-to-head with other scientific advancements

Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab Chaturvedi

Gladstone in the News December 15, 2021

New COVID-19 Nasal Spray Therapy Aims to ‟Reduce Viral Load in the Lungs by 100-Fold”

abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.

Gladstone Experts COVID-19 Virology Weinberger Lab

Gladstone in the News December 14, 2021

Virus-Hijacking COVID-19 Drug from Gladstone Researchers Slows Down Variants, Expects Clinical Trial Early Next Year

San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.

Gladstone Experts COVID-19 Center for Cell Circuitry Virology Weinberger Lab

Article December 9, 2021

A New Class of Antiviral Therapy Could Treat COVID-19

Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus

News Release Research (Publication) COVID-19 Virology Weinberger Lab Chaturvedi

Article December 1, 2021

How Close Are We to a Cure for HIV?

Researchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications

Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger Lab

Article October 6, 2021

Gladstone Investigators Win NIH Director’s Awards

The awards will support high-risk, high-reward research into a fundamentally new type of antiviral and a molecular strategy to fight cancer

Grants News Release COVID-19 Ramani Lab Weinberger Lab

Article July 22, 2021

“Noisy” Gene Expression Plays Key Role in Development and May Help Improve Stem Cell Therapies

Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types

News Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi

Article May 10, 2021

Research Associates in Their Own Words

Three Gladstone research associates describe their work and why they love working at Gladstone

Research Associates Committee Profile McDevitt Lab Weinberger Lab

Gladstone in the News October 30, 2020

Can We Create Vaccines That Mutate and Spread?

TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.

Gladstone Experts HIV/AIDS Center for Cell Circuitry Virology Weinberger Lab

Article July 6, 2020

Herpesviruses Hedge Their Bets to Optimize Survival

Varying levels of proteins in cytomegalovirus particles help the virus survive in different conditions.

News Release Research (Publication) Flow Cytometry Core Virology Weinberger Lab Basic Science Chaturvedi

Article June 28, 2020

Gladstone Investigator Receives an Avant-Garde Award

Leor Weinberger is selected by the National Institute on Drug Abuse for his innovative HIV research

Awards HIV/AIDS Weinberger Lab